SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC) is a proteomics technology company that reached public markets through a merger with CM Life Sciences III Inc. (Nasdaq: CMLF), a special purpose acquisition company sponsored by CMLS Holdings. CM Life Sciences III completed its IPO in 2021 with a focus on the life sciences and healthcare sector. The business combination between SomaLogic and CM Life Sciences III was announced in January 2021; the 10-Q filing dated May 2021 was submitted during the pre-close period of that transaction. The de-SPAC merger closed in September 2021, with SomaLogic's large-scale protein measurement platform subsequently trading under the SLGC ticker on Nasdaq. Sign up on SpacDesk for full filing history, deal timelines, and analytics on SomaLogic and hundreds of other SPAC transactions.